Cargando…
SAT-497 Importance of OTC Medications in Hypercalcemia
Background: Calcium-alkali syndrome, formerly known as milk-alkali syndrome was a classic cause of hypercalcemia until newer therapies for peptic ulcer disease emerged is mostly seen today in osteoporosis prevention and secondary hyperparathyroid treatment in chronic kidney disease. Here we present...
Autores principales: | Yedla, Niharika, Layka, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551837/ http://dx.doi.org/10.1210/js.2019-SAT-497 |
Ejemplares similares
-
SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020) -
SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019) -
SAT-366 Hypercalcemia Due to Castleman’s Disease
por: Khan, Sarah Adil, et al.
Publicado: (2020) -
SAT-359 Hypercalcemia - Is This Sarcoidosis, Hyperparathyroidism, or Both?
por: Veeramachaneni, Ravali, et al.
Publicado: (2020) -
SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019)